NovoMix 50

biphasic insulin aspart 50 · Novo Nordisk A/S

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for NovoMix 50, covering 2016-10-31 to 2017-01-05. Get the full timeline:

Most recent: Clinical Trial Update: Pharmacokinetics and Pharmacodynamics of Biphasic Insulin Aspart 30 and 50 in Subjects With Type 2 Diabetes [Phase 1]

See pricing